‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies

Autor:	Aishwarya Sannareddy, Heather Reves, Madhusudhanan Narasimhan, Kefyalew Jaleta, Julia Marie Anderson, Hetalkumari Patel, Larry D. Anderson, Aimaz Afrough, Stephen Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T Awan, Alagar R Muthukumar, Praveen Ramakrishnan Geethakumari
Rok vydání:	2023
Předmět:	Transplantation Molecular Medicine Immunology and Allergy Cell Biology Hematology
Zdroj:	Transplantation and Cellular Therapy. 29:S330
ISSN:	2666-6367
DOI:	10.1016/s2666-6367(23)00505-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ecc6a00b1966bbb3979148db2228ef55 https://doi.org/10.1016/s2666-6367(23)00505-5 Zobrazit plný text záznamu Full Text from ScienceDirect